Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Revenue by Product

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2015
Pharmaceutical Products	871.91M
Pharmaceutical Products Growth	31.34%

Revenue by Geography

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2015
Egypt	871.91M
Egypt Growth	31.34%